参考文献/References:
[1] Boström P, Wu J, Jedrychowski MP,et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat andthermogenesis[J].Nature, 2012,481(7382):463-468. DOI: 10.1038/nature10777.
[2] Moreno-Navarrete JM, Ortega F, Serrano M,et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity andinsulin resistance[J]. J Clin Endocrinol Metab,2013,98(4):E769-E778. DOI: 10.1210/jc.2012-2749.
[3] Huh JY, Panagiotou G, Mougios V,et al.FNDC5 and irisin in humans:Ⅰ. Predictors of circulating concentrations in serum and plasma and Ⅱ. mRNA expression and circulating concentrations in response to weight loss and exercise[J].Metabolism, 2012,61(12):1725-1738. DOI: 10.1016/j.metabol.2012.09.002.
[4] Xu J, Lloyd DJ, Hale C, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure,and improvesinsulin sensitivity in diet-induced obese mice[J].Diabetes, 2009,58(1):250-259. DOI: 10.2337/db08-0392.
[5] Li D, Zhang Y, Xu L, et al. Regulation of gene expression by FSP27 in white and brown adipose tissue[J]. BMC Genomics,2010,11:446.DOI: 10.1186/1471-2164-11-446.
[6] Shan T, Liang X, Bi P,et al.Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5pathway in muscle[J].FASEB J, 2013,27(5):1981-1989.DOI: 10.1096/fj.12-225755. Epub 2013 Jan 29.
[7] He C, Bassik MC, Moresi V,et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis[J]. Nature,2012,481(7382):511-515.DOI:10.1038/nature10758.
[8] Fisher FM, Kleiner S, Douris N,et al.FGF21 regulates PGC-1α and browning of white adipose tissuesin adaptive thermogenesis[J]. Genes Dev, 2012,26(3):271-281.DOI:10.1101/gad.177857.111.
[9] Zhang HJ, Zhang XF, Ma ZM,et al.Irisin is inversely associated with intrahepatic triglyceride contents in obese adults[J]. J Hepatol,2013,59(3):557-562. DOI: 10.1016/j.jhep.2013.04.030.
[10] Wang C, Guan Y, Yang J.Cytokines in the progression of pancreatic β-cell dysfunction[J]. Int J Endocrinol, 2010,2010:515136. DOI: 10.1155/2010/515136.
[11] Wenz T, Rossi SG, Rotundo RL,et al. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging[J]. Proc Natl Acad Sci U S A, 2009,106(48):20405-20410. DOI: 10.1073/pnas.0911570106.
[12] Sharp LZ, Shinoda K, Ohno H,et al. Human BAT possesses molecular signatures that resemble beige/brite cells[J]. PLoS One, 2012,7(11):e49452. DOI: 10.1371/journal.pone.0049452.
[13] Feldmann HM, Golozoubova V, Cannon B,et al.UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermalstress by living at thermoneutrality[J]. Cell Metab, 2009,9(2):203-209. DOI: 10.1016/j.cmet.2008.12.014.
[14] Stengel A, Hofmann T, Goebel-Stengel M,et al. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlationwith body mass index[J]. Peptides, 2013,39:125-130. DOI: 10.1016/j.peptides.2012.11.014.
[15] Choi YK, Kim MK, Bae KH, et al. Serum irisin levels in new-onset type 2 diabetes[J].Diabetes Res Clin Pract, 2013,100(1):96-101. DOI: 10.1016/j.diabres.2013.01.007.
[16] 潘玲玲,张惠杰,陈政,等.血清irisin水平与腹型肥胖成人体脂率相关[J].中华糖尿病杂志,2013,5(8):472-476.DOI: 10.3760/cma.j.issn.1674-5809.2013.08.005.
[17] Sharma N, Castorena CM, Cartee GD.Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines[J]. Nutr Metab(Lond), 2012,9(1):90. DOI: 10.1186/1743-7075-9-90.
[18] Hernández-Alvarez MI, Thabit H, Burns N,et al.Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity[J]. Diabetes Care, 2010,33(3):645-651. DOI: 10.2337/dc09-1305.
[19] Timmons JA, Baar K, Davidsen PK,et al.Is irisin a human exercise gene?[J].Nature, 2012,488(7413):E9-E10; discussion E10-1. DOI: 10.1038/nature11364.
[20] Raschke S, Elsen M, Gassenhuber H,et al. Evidence against a beneficial effect of irisin in humans[J]. PLoS One, 2013,8(9):e73680. DOI: 10.1371/journal.pone.0073680.
相似文献/References:
[1]刘璐,李鸿.代谢调控的新靶点——Irisin[J].国际内分泌代谢杂志,2014,(02):109.[doi:10.3760/cma.j.issn.1673-4157.2014.02.011]
Liu Lu,Li Hong..A new target in metabolic control--Irisin[J].International Journal of Endocrinology and Metabolism,2014,(01):109.[doi:10.3760/cma.j.issn.1673-4157.2014.02.011]
[2]谢绍锋,黄莉吉,王昆,等.南京市城区40岁以上人群超重、肥胖流行
特点调查分析[J].国际内分泌代谢杂志,2016,36(03):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
Xie Shaofeng*,Huang Liji,Wang Kun,et al.Epidemiological investigation of overweight and obesity in population aged 40 years or older in Nanjing City[J].International Journal of Endocrinology and Metabolism,2016,36(01):145.[doi:10.3760/cma.j.issn.1673-4157.2016.03.01]
[3]祝凌妃,杨震,秦利.肌肉因子与代谢性疾病[J].国际内分泌代谢杂志,2016,36(05):355.[doi:10.3760/cma.j.issn.1673-4157.2016.05.19]
Zhu Lingfei,Yang Zhen,Qin li.Myokines and metabolic disease[J].International Journal of Endocrinology and Metabolism,2016,36(01):355.[doi:10.3760/cma.j.issn.1673-4157.2016.05.19]
[4]项芬芬,张学梅,高英慧,等.p53与物质能量代谢的关系[J].国际内分泌代谢杂志,2017,37(04):262.
Xiang Fenfen*,Zhang Xuemei,Gao Yinghui,et al.Relationship between p53 and material, energy metabolism[J].International Journal of Endocrinology and Metabolism,2017,37(01):262.
[5]杨雪 相萍萍 陈国芳 刘超.IGF-1在代谢性疾病中的作用[J].国际内分泌代谢杂志,2018,38(01):33.[doi:10.3760/cma.j.issn.1673-4157.2018.01.009]
Yang Xue,Xiang Pingping,Chen Guofang,et al.Effects of IGF-1 in metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(01):33.[doi:10.3760/cma.j.issn.1673-4157.2018.01.009]
[6]杨雪 韦晓 杨婉薇 陈国芳 刘超.代谢组学在糖尿病研究中的应用[J].国际内分泌代谢杂志,2018,38(05):343.[doi:10.3760/cma.j.issn.1673-4157.2018.05.015]
Yang Xue,Wei Xiao,Yang Wanwei,et al.Application of metabonomics in diabetic research[J].International Journal of Endocrinology and Metabolism,2018,38(01):343.[doi:10.3760/cma.j.issn.1673-4157.2018.05.015]
[7]王佳蓓 陈风 刘莹 王涤非.Nur77与物质能量代谢的关系[J].国际内分泌代谢杂志,2019,39(01):49.[doi:10.3760/cma.j.issn.1673-4157.2019.01.012]
Wang Jiabei,Chen Feng,Liu Ying,et al.Relationship between Nur77 and meterial, energy metabolism[J].International Journal of Endocrinology and Metabolism,2019,39(01):49.[doi:10.3760/cma.j.issn.1673-4157.2019.01.012]
[8]王雪 朱惠娟 龚凤英.棕色脂肪因子与代谢性疾病[J].国际内分泌代谢杂志,2019,39(06):409.[doi:10.3760/cma.j.issn.1673-4157.2019.06.012]
Wang Xue,Zhu Huijuan,Gong Fengying.Relationship between brown adipocytokine and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2019,39(01):409.[doi:10.3760/cma.j.issn.1673-4157.2019.06.012]
[9]王鹏程,姜长涛.肠源神经酰胺与代谢性疾病[J].国际内分泌代谢杂志,2021,41(04):295.[doi:10.3760/cma.j.cn121383-20200610-06029]
Wang Pengcheng,Jiang Changtao..Relationship between intestinal ceramide and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2021,41(01):295.[doi:10.3760/cma.j.cn121383-20200610-06029]
[10]乔晶,刘乙君,王彦.甘油三酯-葡萄糖指数与胰岛素抵抗相关代谢性疾病的关系[J].国际内分泌代谢杂志,2022,42(03):223.[doi:10.3760/cma.j.cn121383-20210206-02013]
QiaoJing,LiuYijun,WangYan..Relationship between triglyceride-glucose index and insulin resistance-related metabolic diseases[J].International Journal of Endocrinology and Metabolism,2022,42(01):223.[doi:10.3760/cma.j.cn121383-20210206-02013]
[11]艾华,谢岚.Irisin与代谢性疾病的关系[J].国际内分泌代谢杂志,2014,(05):316.[doi:10.3760/cma.j.issn.1673-4157.2014.05.008]
Ai Hua,Xie Lan.Relationship between irisin and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(01):316.[doi:10.3760/cma.j.issn.1673-4157.2014.05.008]